The present and future of cough counting tools
Jocelin Isabel Hall1, Manuel Lozano2,3,4, Luis Estrada-Petrocelli2,3,5
1Centre for Human and Applied Physiological Sciences, King's College London, London, UK.
Journal of Thoracic Disease
|November 4, 2020
Summary
Automated cough counting technology is advancing, moving beyond human input to measure respiratory disease. Future developments promise real-time, mobile-based monitoring for broader clinical applications.
Area of Science:
- Respiratory Medicine
- Biomedical Engineering
- Digital Health
Background:
- Cough frequency measurement historically relied on manual input, limiting its widespread use.
- Advances in digital audio technology have enabled more objective cough counting.
- Cough frequency is now a key metric in respiratory disease research and clinical trials.
Purpose of the Study:
- To review the principles and current technologies for automatic cough detection.
- To summarize existing and recent cough counting tools used in clinical research.
- To predict future directions in automated cough monitoring.
Main Methods:
- Discussion of signal processing principles for cough detection.
- Review of current and recent cough counting technologies in clinical research.
- Analysis of emerging trends like speech recognition and mobile device integration.
Main Results:
- Digital technology has reduced dependence on human input for cough frequency assessment.
- Cough frequency is recognized as a measurable parameter for respiratory diseases like chronic cough, tuberculosis (TB), and chronic obstructive pulmonary disease (COPD).
- Current technologies are transitioning from niche research tools to potentially wider applications.
Conclusions:
- Future developments in signal processing and mobile technology will drive real-time, automated ambulatory cough monitoring.
- Automated cough counting systems are poised to become widely applicable tools for assessing and understanding respiratory diseases.
- This shift will enhance the investigation and management of various respiratory conditions.
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
725
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
725
Pulmonary Function Tests
587
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
587
Physical Assessment of the Respiratory Tract I: Health History
703
Physical assessment of the respiratory tract is critical to patient care. It allows healthcare professionals to identify and manage various respiratory conditions. The process involves a combination of subjective and objective data collection.
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
703
Drugs Used in Lower Respiratory Disorders: Overview
867
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
867
Respiratory Volumes and Capacities
4.2K
The respiratory system is responsible for the intake of oxygen and the expulsion of carbon dioxide from the body. Respiratory volumes describe the volume of air in the lungs at different phases of the respiratory cycle. Tidal volume is the air breathed in and out during normal, quiet breathing. Inspiratory reserve volume is the air that can be forcefully inspired beyond the tidal volume. In contrast, expiratory reserve volume refers to the air that can be expelled from the lungs after a normal...
4.2K
Drugs Used in Upper Respiratory Disorders: Overview
499
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
499


